30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Trevi Therapeutics Inc (TRVI)

Track

Stock chart
Ticker: TRVI Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Delfini Lisa
Officer
1 sale — total 1,032,175 USD
Proposed sale 7 Oct 2025
Value US$2,370,858.89 | Price 310.12 | Shares 98,131
Proposed sale 3 Oct 2025
Value US$2,185,045.03 | Price 463.85 | Shares 31,709
Proposed sale 27 Aug 2025
Value US$2,532,530.00 | Price 8.09 | Shares 312,855
Sale 25 Mar 2025
Value US$17,364.60 | Price 6.60 | Shares 2,631
Sale 21 Mar 2025
Value US$34,624.75 | Price 6.58 | Shares 5,263
Proposed sale 21 Mar 2025
Value US$34,625.00 | Price 6.58 | Shares 5,263
Planned sale 10 Mar 2025
Value US$31,101.63 | Price 7.15 | Shares 4,350
Planned sale 10 Mar 2025
Value US$517,776.28 | Price 6.73 | Shares 76,963
Proposed sale 10 Mar 2025
Value US$548,880.07 | Price 6.75 | Shares 81,313
Sale 9 Sep 2024
Value US$5,586.61 | Price 3.04 | Shares 1,840
Sale 6 Sep 2024
Value US$12,784.41 | Price 3.03 | Shares 4,219
Sale 5 Sep 2024
Value US$125,309.80 | Price 3.11 | Shares 40,277
Sale 4 Sep 2024
Value US$33,205.45 | Price 3.02 | Shares 10,981
Sale 3 Sep 2024
Value US$11,677.46 | Price 3.02 | Shares 3,863
Proposed sale 3 Sep 2024
Value US$193,328.00 | Price 3.16 | Shares 61,180
Sale 27 Aug 2024
Value US$13,352.53 | Price 2.93 | Shares 4,555
Proposed sale 27 Aug 2024
Value US$13,573.00 | Price 2.98 | Shares 4,555
Sale 19 Aug 2024
Value US$48,882.60 | Price 2.96 | Shares 16,496
Sale 16 Aug 2024
Value US$51,440.02 | Price 2.76 | Shares 18,660
Sale 15 Aug 2024
Value US$35,512.67 | Price 2.79 | Shares 12,745
Proposed sale 15 Aug 2024
Value US$125,282.00 | Price 2.61 | Shares 48,001
Proposed sale 15 Aug 2024
Value US$125,282.00 | Price 2.61 | Shares 48,001
Sale 14 Aug 2024
Value US$275.00 | Price 2.75 | Shares 100
Planned sale 29 May 2024
Value US$136,109.75 | Price 2.55 | Shares 53,368
Proposed sale 29 May 2024
Value US$136,622.00 | Price 2.56 | Shares 53,368
Planned sale 22 May 2024
Value US$11,484.87 | Price 2.64 | Shares 4,350
Sale 20 May 2024
Value US$71,575.78 | Price 2.86 | Shares 25,037
Planned sale 10 May 2024
Value US$13,276.20 | Price 2.90 | Shares 4,578
Planned sale 11 Oct 2023
Value US$1,585.70 | Price 2.02 | Shares 785
Planned sale 11 Sep 2023
Value US$1,564.20 | Price 2.20 | Shares 711
Proposed sale 11 Sep 2023
Value US$3,456.00 | Price 2.16 | Shares 1,600
Planned sale 11 Aug 2023
Value US$1,609.52 | Price 2.36 | Shares 682
Planned sale 11 Jul 2023
Value US$1,607.58 | Price 2.34 | Shares 687
Planned sale 12 Jun 2023
Value US$1,610.40 | Price 2.64 | Shares 610
Proposed sale 12 Jun 2023
Value US$4,150.00 | Price 2.57 | Shares 1,615
Planned sale 11 May 2023
Value US$1,624.18 | Price 2.89 | Shares 562
Planned sale 11 Apr 2023
Value US$1,544.76 | Price 1.84 | Shares 840
Proposed sale 11 Apr 2023
Value US$3,496.00 | Price 1.84 | Shares 1,900
Planned sale 13 Mar 2023
Value US$1,563.85 | Price 1.75 | Shares 892
Planned sale 13 Feb 2023
Value US$20,761.30 | Price 2.45 | Shares 8,474
Sale 5 Jul 2022
Value US$197,826.73 | Price 3.11 | Shares 63,569
Sale 1 Jul 2022
Value US$1,246,185.08 | Price 2.86 | Shares 436,431
Sale 30 Jun 2022
Value US$1,191,897.79 | Price 2.77 | Shares 429,838
Sale 29 Jun 2022
Value US$126,303.08 | Price 2.74 | Shares 46,128
Sale 2 May 2022
Value US$1,620.00 | Price 2.70 | Shares 600
Sale 29 Apr 2022
Value US$44,385.21 | Price 2.75 | Shares 16,163
Sale 28 Apr 2022
Value US$20,139.94 | Price 2.77 | Shares 7,271
Buy 11 Apr 2022
Value US$4,999,998.20 | Price 1.90 | Shares 2,631,578
Buy 11 Apr 2022
Value US$4,999,998.20 | Price 1.90 | Shares 2,631,578
Buy 11 Apr 2022
Value US$1,803,001.20 | Price 1.90 | Shares 948,948
Buy 11 Apr 2022
Value US$4,999,998.20 | Price 1.90 | Shares 2,631,578
Buy 11 Apr 2022
Value US$1,803,001.20 | Price 1.90 | Shares 948,948
Buy 11 Apr 2022
Value US$4,999,998.20 | Price 1.90 | Shares 2,631,578
Buy 11 Apr 2022
Value US$1,803,001.20 | Price 1.90 | Shares 948,948
Buy 11 Apr 2022
Value US$4,999,998.20 | Price 1.90 | Shares 2,631,578
Buy 11 Apr 2022
Value US$1,803,001.20 | Price 1.90 | Shares 948,948
Buy 11 Apr 2022
Value US$4,999,998.20 | Price 1.90 | Shares 2,631,578
Buy 11 Apr 2022
Value US$1,803,001.20 | Price 1.90 | Shares 948,948
Buy 11 Apr 2022
Value US$4,999,998.20 | Price 1.90 | Shares 2,631,578
Buy 11 Apr 2022
Value US$1,803,001.20 | Price 1.90 | Shares 948,948
Buy 11 Apr 2022
Value US$4,999,998.20 | Price 1.90 | Shares 2,631,578
Buy 11 Apr 2022
Value US$1,803,001.20 | Price 1.90 | Shares 948,948
Buy 11 Apr 2022
Value US$4,999,998.20 | Price 1.90 | Shares 2,631,578
Buy 18 Oct 2021
Value US$0.00 | Price 0.00 | Shares 1,851,852
Buy 18 Oct 2021
Value US$0.00 | Price 0.00 | Shares 1,851,852
Buy 18 Oct 2021
Value US$0.00 | Price 0.00 | Shares 1,851,852
Buy 18 Oct 2021
Value US$0.00 | Price 0.00 | Shares 1,851,852
Buy 18 Oct 2021
Value US$0.00 | Price 0.00 | Shares 1,851,852
Buy 18 Oct 2021
Value US$0.00 | Price 0.00 | Shares 1,851,852
Buy 18 Oct 2021
Value US$0.00 | Price 0.00 | Shares 1,851,852
Buy 18 Oct 2021
Value US$0.00 | Price 0.00 | Shares 1,851,852
Buy 18 Oct 2021
Value US$0.00 | Price 0.00 | Shares 1,851,852
Sale 3 Apr 2020
Value US$1,500.24 | Price 2.66 | Shares 564
Sale 3 Apr 2020
Value US$1,500.24 | Price 2.66 | Shares 564
Sale 3 Apr 2020
Value US$1,500.24 | Price 2.66 | Shares 564
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-07 2025-10-07 PrS Proposed sale
Delfini Lisa

Officer

Officer
98,131
310.12
US$2,370,859 		98,131 310.12 US$2,370,859
2025-10-03 2025-10-03 PrS Proposed sale
Delfini Lisa

Officer

Officer
31,709
463.85
US$2,185,045 		31,709 463.85 US$2,185,045
2025-08-27 2025-08-27 PrS Proposed sale
Delfini Lisa

Officer

Officer
96,851
202.71
US$3,535,503 		96,851 202.71 US$3,535,503
2025-03-26 2025-03-25 S Sale
1.7
SCIASCIA THOMAS

Chief Scientific Officer

Officer
2,631 -1.2%
6.60
US$17,365 		2,631 -1.2% 6.60 US$17,365
2025-03-25 2025-03-21 S Sale
2.9
GOOD JENNIFER L

President & CEO

Executive Director
5,263 -2.4%
6.58
US$34,625 		5,263 -2.4% 6.58 US$34,625
2025-03-21 2025-03-21 PrS Proposed sale
2.9
GOOD JENNIFER L

Officer

Officer
5,263
6.58
US$34,625 		5,263 6.58 US$34,625
2025-03-12 2025-03-10 PlS Planned sale
Simon Farrell

Chief Commercial Officer

Officer
4,350 -5.4%
7.15
US$31,102 		4,350 -5.4% 7.15 US$31,102
2025-03-12 2025-03-10 PlS Planned sale
Simon Farrell

Chief Commercial Officer

Officer
76,963 -48.6%
6.73
US$517,776 		76,963 -48.6% 6.73 US$517,776
2025-03-10 2025-03-10 PrS Proposed sale
Simon Farrell

Officer

Officer
81,313
6.75
US$548,880 		81,313 6.75 US$548,880
2024-09-09 2024-09-09 S Sale
2.9
GOOD JENNIFER L

President & CEO

Executive Director
1,840 -0.9%
3.04
US$5,587 		1,840 -0.9% 3.04 US$5,587
2024-09-09 2024-09-06 S Sale
2.9
GOOD JENNIFER L

President & CEO

Executive Director
4,219 -1.9%
3.03
US$12,784 		4,219 -1.9% 3.03 US$12,784
2024-09-05 2024-09-05 S Sale
2.9
GOOD JENNIFER L

President & CEO

Executive Director
40,277 -15.9%
3.11
US$125,310 		40,277 -15.9% 3.11 US$125,310
2024-09-05 2024-09-04 S Sale
2.9
GOOD JENNIFER L

President & CEO

Executive Director
10,981 -4.9%
3.02
US$33,205 		10,981 -4.9% 3.02 US$33,205
2024-09-05 2024-09-03 S Sale
2.9
GOOD JENNIFER L

President & CEO

Executive Director
3,863 -1.8%
3.02
US$11,677 		3,863 -1.8% 3.02 US$11,677
2024-09-03 2024-09-03 PrS Proposed sale
2.9
GOOD JENNIFER L

Officer

Officer
61,180
3.16
US$193,328 		61,180 3.16 US$193,328
2024-08-29 2024-08-27 S Sale
1.2
Meeker David P
Non-Executive Director
4,555 -1.3%
2.93
US$13,353 		4,555 -1.3% 2.93 US$13,353
2024-08-27 2024-08-27 PrS Proposed sale
1.2
Meeker David P

Officer

Officer
4,555
2.98
US$13,573 		4,555 2.98 US$13,573
2024-08-21 2024-08-19 S Sale
1.7
SCIASCIA THOMAS

Chief Scientific Officer

Officer
16,496 -7.0%
2.96
US$48,883 		16,496 -7.0% 2.96 US$48,883
2024-08-16 2024-08-16 S Sale
1.7
SCIASCIA THOMAS

Chief Scientific Officer

Officer
18,660 -7.8%
2.76
US$51,440 		18,660 -7.8% 2.76 US$51,440
2024-08-16 2024-08-15 S Sale
1.7
SCIASCIA THOMAS

Chief Scientific Officer

Officer
12,745 -5.5%
2.79
US$35,513 		12,745 -5.5% 2.79 US$35,513
2024-08-15 2024-08-15 PrS Proposed sale
1.7
SCIASCIA THOMAS

Officer

Officer
48,001
2.61
US$125,282 		48,001 2.61 US$125,282
2024-08-15 2024-08-15 PrS Proposed sale
1.7
SCIASCIA THOMAS

Officer

Officer
48,001
2.61
US$125,282 		48,001 2.61 US$125,282
2024-08-16 2024-08-14 S Sale
1.7
SCIASCIA THOMAS

Chief Scientific Officer

Officer
100 -0.0%
2.75
US$275 		100 -0.0% 2.75 US$275
2024-05-31 2024-05-29 PlS Planned sale
1.7
SCIASCIA THOMAS

Chief Scientific Officer

Officer
53,368 -19.9%
2.55
US$136,110 		53,368 -19.9% 2.55 US$136,110
2024-05-29 2024-05-29 PrS Proposed sale
1.7
SCIASCIA THOMAS

Officer

Officer
53,368
2.56
US$136,622 		53,368 2.56 US$136,622
2024-05-24 2024-05-22 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
4,350 -7.5%
2.64
US$11,485 		4,350 -7.5% 2.64 US$11,485
2024-05-22 2024-05-20 S Sale
2.9
GOOD JENNIFER L

President & CEO

Executive Director
25,037 -10.5%
2.86
US$71,576 		25,037 -10.5% 2.86 US$71,576
2024-05-14 2024-05-10 PlS Planned sale
2.9
GOOD JENNIFER L

President & CEO

Executive Director
4,578 -2.1%
2.90
US$13,276 		4,578 -2.1% 2.90 US$13,276
2023-10-12 2023-10-11 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
785 -2.1%
2.02
US$1,586 		785 -2.1% 2.02 US$1,586
2023-09-13 2023-09-11 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
711 -2.0%
2.20
US$1,564 		711 -2.0% 2.20 US$1,564
2023-09-11 2023-09-11 PrS Proposed sale
Delfini Lisa

Officer

Officer
1,600
2.16
US$3,456 		1,600 2.16 US$3,456
2023-08-14 2023-08-11 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
682 -2.0%
2.36
US$1,610 		682 -2.0% 2.36 US$1,610
2023-07-12 2023-07-11 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
687 -2.2%
2.34
US$1,608 		687 -2.2% 2.34 US$1,608
2023-06-14 2023-06-12 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
610 -2.0%
2.64
US$1,610 		610 -2.0% 2.64 US$1,610
2023-06-12 2023-06-12 PrS Proposed sale
Delfini Lisa

Officer

Officer
1,615
2.57
US$4,150 		1,615 2.57 US$4,150
2023-05-15 2023-05-11 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
562 -2.0%
2.89
US$1,624 		562 -2.0% 2.89 US$1,624
2023-04-12 2023-04-11 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
840 -3.1%
1.84
US$1,545 		840 -3.1% 1.84 US$1,545
2023-04-11 2023-04-11 PrS Proposed sale
Delfini Lisa

Officer

Officer
1,900
1.84
US$3,496 		1,900 1.84 US$3,496
2023-03-15 2023-03-13 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
892 -3.5%
1.75
US$1,564 		892 -3.5% 1.75 US$1,564
2023-02-15 2023-02-13 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
8,474 -26.6%
2.45
US$20,761 		8,474 -26.6% 2.45 US$20,761
2022-07-06 2022-07-05 S Sale
3.2
TPG GP A, LLC
63,569 -1.6%
3.11
US$197,827 		63,569 -1.6% 3.11 US$197,827
2022-07-06 2022-07-01 S Sale
3.2
TPG GP A, LLC
436,431 -10.1%
2.86
US$1,246,185 		436,431 -10.1% 2.86 US$1,246,185
2022-07-01 2022-06-30 S Sale
3.2
TPG GP A, LLC
Large shareholder
429,838 -9.0%
2.77
US$1,191,898 		429,838 -9.0% 2.77 US$1,191,898
2022-07-01 2022-06-29 S Sale
3.2
TPG GP A, LLC
Large shareholder
46,128 -1.0%
2.74
US$126,303 		46,128 -1.0% 2.74 US$126,303
2022-05-04 2022-05-02 S Sale
3.2
TPG GP A, LLC
Large shareholder
600 -0.0%
2.70
US$1,620 		600 -0.0% 2.70 US$1,620
2022-05-02 2022-04-29 S Sale
3.2
TPG GP A, LLC
Large shareholder
16,163 -0.3%
2.75
US$44,385 		16,163 -0.3% 2.75 US$44,385
2022-05-02 2022-04-28 S Sale
3.2
TPG GP A, LLC
Large shareholder
7,271 -0.2%
2.77
US$20,140 		7,271 -0.2% 2.77 US$20,140
2022-04-13 2022-04-11 B Purchase
1.2
New Enterprise Associates 16, L.P.
Large shareholder
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2022-04-13 2022-04-11 B Purchase
2.5
BASKETT FOREST
Large shareholder
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2022-04-13 2022-04-11 B Purchase
3.9
Walker Paul Edward
Large shareholder
948,948 +inf%
1.90
US$1,803,001 		948,948 +inf% 1.90 US$1,803,001
2022-04-13 2022-04-11 B Purchase
3.9
Walker Paul Edward
Large shareholder
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2022-04-13 2022-04-11 B Purchase
2.7
Makhzoumi Mohamad
Large shareholder
948,948 +inf%
1.90
US$1,803,001 		948,948 +inf% 1.90 US$1,803,001
2022-04-13 2022-04-11 B Purchase
2.7
Makhzoumi Mohamad
Large shareholder
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2022-04-13 2022-04-11 B Purchase
1.5
Behbahani Ali
Large shareholder
948,948 +inf%
1.90
US$1,803,001 		948,948 +inf% 1.90 US$1,803,001
2022-04-13 2022-04-11 B Purchase
1.5
Behbahani Ali
Large shareholder
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2022-04-13 2022-04-11 B Purchase
2.4
SANDELL SCOTT D
Large shareholder
948,948 +inf%
1.90
US$1,803,001 		948,948 +inf% 1.90 US$1,803,001
2022-04-13 2022-04-11 B Purchase
2.4
SANDELL SCOTT D
Large shareholder
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2022-04-13 2022-04-11 B Purchase
3.5
Chang Carmen
Large shareholder
948,948 +inf%
1.90
US$1,803,001 		948,948 +inf% 1.90 US$1,803,001
2022-04-13 2022-04-11 B Purchase
3.5
Chang Carmen
Large shareholder
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2022-04-13 2022-04-11 B Purchase
2.1
Sonsini Peter W.
Large shareholder
948,948 +inf%
1.90
US$1,803,001 		948,948 +inf% 1.90 US$1,803,001
2022-04-13 2022-04-11 B Purchase
2.1
Sonsini Peter W.
Large shareholder
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2022-04-13 2022-04-11 B Purchase
2.6
Florence Anthony A. Jr.
Large shareholder
948,948 +inf%
1.90
US$1,803,001 		948,948 +inf% 1.90 US$1,803,001
2022-04-13 2022-04-11 B Purchase
2.6
Florence Anthony A. Jr.
Large shareholder
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2021-10-19 2021-10-18 B Purchase
1.2
New Enterprise Associates 16, L.P.
Large shareholder
1,851,852
0.00
US$0 		1,851,852 0.00 US$0
2021-10-19 2021-10-18 B Purchase
1.5
Behbahani Ali
Large shareholder
1,851,852
0.00
US$0 		1,851,852 0.00 US$0
2021-10-19 2021-10-18 B Purchase
3.5
Chang Carmen
Large shareholder
1,851,852
0.00
US$0 		1,851,852 0.00 US$0
2021-10-19 2021-10-18 B Purchase
2.5
BASKETT FOREST
Large shareholder
1,851,852
0.00
US$0 		1,851,852 0.00 US$0
2021-10-19 2021-10-18 B Purchase
2.6
Florence Anthony A. Jr.
Large shareholder
1,851,852
0.00
US$0 		1,851,852 0.00 US$0
2021-10-19 2021-10-18 B Purchase
2.7
Makhzoumi Mohamad
Large shareholder
1,851,852
0.00
US$0 		1,851,852 0.00 US$0
2021-10-19 2021-10-18 B Purchase
2.4
SANDELL SCOTT D
Large shareholder
1,851,852
0.00
US$0 		1,851,852 0.00 US$0
2021-10-19 2021-10-18 B Purchase
2.1
Sonsini Peter W.
Large shareholder
1,851,852
0.00
US$0 		1,851,852 0.00 US$0
2021-10-19 2021-10-18 B Purchase
3.9
Walker Paul Edward
Large shareholder
1,851,852
0.00
US$0 		1,851,852 0.00 US$0
2020-04-13 2020-04-03 S Sale
1.2
New Enterprise Associates 16, L.P.
Large shareholder
564 -0.0%
2.66
US$1,500 		564 -0.0% 2.66 US$1,500
2020-04-13 2020-04-03 S Sale
2.7
Makhzoumi Mohamad
Large shareholder
564 -0.0%
2.66
US$1,500 		564 -0.0% 2.66 US$1,500
2020-04-13 2020-04-03 S Sale
2.1
MAKOWER JOSHUA
Large shareholder
564 -0.0%
2.66
US$1,500 		564 -0.0% 2.66 US$1,500
Explore more

More insider trading research around Trevi Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America